Internal Medicine, Pulmonary Disease · Shelbyville, IN
NPI
1659339927
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2451 Intelliplex Dr, Suite 205
Shelbyville, IN, 46176
Phone (317) 421-1914
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
1,404 services
Medicare patients, 2024
534
Average age 72
Drug cost, 2024
$5.6M
7,552 prescriptions
Company payments, 2025
$2,433
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert G Shellman was code 99214 (office e&m - established), 318 times for 234 patients. In total Robert G Shellman billed 1,404 services in 39 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 318 | 234 | $86.54 | $28K |
| 94010 Pulmonary Function Testing | Facility | 209 | 188 | $5.52 | $1,154 |
| 94618 Pulmonary Function Testing | Facility | 136 | 119 | $15.08 | $2,051 |
| 94729 Pulmonary Function Testing | Facility | 119 | 119 | $5.69 | $678 |
| 94726 Pulmonary Function Testing | Facility | 116 | 115 | $7.80 | $905 |
| 94060 Pulmonary Function Testing | Facility | 94 | 94 | $6.99 | $657 |
| 94660 Treatment - Miscellaneous | Office | 84 | 67 | $41.90 | $3,520 |
| 99204 Office E&M - New | Office | 72 | 72 | $113.74 | $8,190 |
| 95810 Sleep Study | Facility | 56 | 56 | $76.34 | $4,275 |
| 95811 Sleep Study | Facility | 35 | 33 | $85.94 | $3,008 |
| 95806 Sleep Study | Facility | 21 | 21 | $27.05 | $568 |
| 99211 Office E&M - Established | Office | 18 | 18 | $17.10 | $308 |
| 69209 Other Organ Systems | Office | 12 | 11 | $14.75 | $177 |
By year: 2022 $84K for 1,829 services; 2023 $76K for 1,635 services; 2024 $59K for 1,404 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert G Shellman prescribed most often to Medicare patients was Azelastine Hcl, with 931 prescriptions and refills. In total Robert G Shellman wrote 7,552 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 931 | 1,617 | 293 | $26K |
| Fluticasone Propionate Generic | 874 | 1,553 | 340 | $12K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 641 | 867 | 157 | $548K |
| Azithromycin Generic | 581 | 751 | 126 | $3,489 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 368 | 398 | 104 | $6,785 |
| Arnuity Ellipta Fluticasone Furoate | 257 | 345 | 52 | $79K |
| Roflumilast Generic | 247 | 345 | 53 | $21K |
| Spiriva Respimat Tiotropium Bromide | 237 | 306 | 61 | $159K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 213 | 267 | 37 | $127K |
| Breo Ellipta Fluticasone/Vilanterol | 191 | 225 | 40 | $89K |
| Bupropion Hcl Sr Bupropion Hcl | 186 | 268 | 59 | $4,212 |
| Qvar Redihaler Beclomethasone Dipropionate | 181 | 212 | 33 | $59K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 172 | 210 | 27 | $97K |
| Theophylline Er Theophylline Anhydrous | 114 | 154 | 34 | $5,172 |
| Paroxetine Hcl Generic | 110 | 189 | 32 | $1,518 |
Brand drugs: 3,222 claims; generic drugs: 4,330 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert G Shellman $2,433 ($2,433 in general payments such as food, travel and fees) from 23 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $691.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 19 | $691 |
| GlaxoSmithKline, LLC. GSK | 15 | $220 |
| Axsome Therapeutics, Inc. AXSM | 10 | $188 |
| Verona Pharma, Inc. VRNA | 17 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $174 |
| Insmed, Inc. INSM | 14 | $155 |
| Jazz Pharmaceuticals Inc. JAZZ | 5 | $124 |
| Genzyme Corporation SNY | 5 | $96.27 |
| Amgen Inc. AMGN | 4 | $87.65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $73.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.